ApconiX Welcomes Dr Craig Thomas ApconiX is delighted to welcome Dr Craig Thomas who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Craig has thirty-four years of drug discovery and management experience in the pharmaceutical industry. Working in both drug discovery, regulatory [...]
ApconiX Welcomes Dr Amy Shepherd ApconiX is delighted to welcome Dr Amy Shepherd who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Amy is an experienced immunologist having worked for over 10 years in nonclinical and clinical safety program design with both [...]
ApconiX Welcomes Scott Hackford ApconiX is delighted to welcome Scott Hackford who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Scott has over 12 years’ experience in a contract research organisation as a study director and lead toxicologist designing, conducting, and reporting [...]
ApconiX Welcomes Bethan Kelly ApconiX is delighted to welcome Bethan Kelly who joins for a years’ placement having just completed her second year of a bachelor’s degree in biology. Bethan becomes part of the ion channel laboratory team and will be working with Dr Michael Morton. Studying Biology Bethan [...]
Celebrating the Link Between hERG and Whiskey Come and help us celebrate the link between hERG and whiskey at our Booth #A6. We’ll be at the ELRIG Drug Discovery 2022 on the 4th and 5th of October, 2022, in London, UK. hERG and Whiskey We’ll be giving away ApconiX [...]
ApconiX Welcomes Dr Kerry Illston ApconiX is delighted to welcome Dr Kerry Illston who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Kerry is an experienced Project Manager with over 25 years’ experience in molecular toxicology, new target identification/validation and nonclinical safety [...]
Queen's Award Celebration On Tuesday the 6th of September Lady Redmond, Lord Lieutenant of Cheshire came to Alderley Park to present ApconiX with the Queen’s Award for Enterprise in recognition of excellence in international trade. Lady Redmond, accompanied by Sir Philip Redmond, presented the certificate to the directors and co-founders Dr Richard Knight, [...]
ApconiX Welcomes Michelle Blissett ApconiX is delighted to welcome Michelle Blissett who joins the Acuity Target Safety Assessment team working with Professor Ruth Roberts and Dr James Sidaway. With almost 20 years devoted to preclinical toxicology, Michelle has developed an excellent ability to conduct extensive literature searches, interrogating, analysing [...]
ApconiX Welcomes William Humfrey ApconiX is delighted to welcome William Humfrey who joins the Acuity Target Safety Assessment team working with Professor Ruth Roberts and Dr James Sidaway. Will studied for an integrated master’s degree in biomedical science at the University of Sheffield where he gained understanding of human [...]
Platelet Function Testing in Target Safety Assessments Adverse Findings Adverse findings in non-clinical safety/toxicity testing continue to be a major reason for failure and/or complexity in drug projects. Since primary target-related toxicity plays a role in a significant proportion of these failures, an in-depth assessment of potential adverse consequences [...]
